Clinical experience with cabazitaxel in patients with metastatic castrate resistant prostate cancer (ECLIPSE) (ELIPSE)

First published 11/07/2017

Last updated 02/07/2024

EU PAS number:

EUPAS19826

Study

Finalised

Download as PDF

Documents

Study protocol

Study results

Study results

SR Synopsis v1.0 07Nov2016-anonymised scan

English (2.75 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents